Trial Profile
Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Ritonavir (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- 14 Oct 2015 New trial record